Company / Shareholders' Equity
IRADIMED CORP Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$94.6M
FY2025
5-year range
$61.4M / $94.6M
FY2021-FY2025
Trend
+9.0%
vs FY2024
Sector context
#146 of 161
Health Care
What the data says
Among 161 Health Care companies, IRADIMED CORP is in the bottom 9% for shareholders' equity. Shareholders' Equity has fluctuated over the past 10 years, ranging from $21M in FY2016 to $95M in FY2025.
Based on SEC 10-K filings.
$95M in FY2025 with a 5-year CAGR of +9.0%.
Improved from $71M to $95M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 161This company $94.6M Sector average $5.1B
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.0%, indicating consistent growth.
- In FY2025, shareholders' equity increased 9.0% year-over-year.
- Ranks #146 out of 161 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $94.6M | +9.0% |
| FY2024 | $86.8M | +21.6% |
| FY2023 | $71.4M | -1.0% |
| FY2022 | $72.2M | +17.6% |
| FY2021 | $61.4M | +0.0% |
| FY2020 | $61.4M | +10.6% |
| FY2019 | $55.5M | +74.1% |
| FY2018 | $31.9M | -0.1% |
| FY2017 | $31.9M | +52.9% |
| FY2016 | $20.9M | +285.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026